Department of Medicine

Advocacy group’s gift boosts lung cancer research efforts

An advocacy group for patients with anaplastic lymphoma kinase positive lung cancer has awarded a $500,000 grant dedicated to overcoming treatment resistance to the cancer.

Nashville VA dialysis unit named in Stone’s honor

The Nashville Veterans Affairs Medical Center has dedicated its dialysis unit to William Stone, MD, a nephrologist and professor of Medicine at VUMC

Team tracks integrin’s role in lung function

Beta-1 integrin, a critical component of epithelial extracellular matrix receptors, is essential for normal lung function in adulthood, researchers at VUMC have discovered.

Vanderbilt-Ingram Cancer Center researchers included in ASCO annual report

Two researchers from Vanderbilt-Ingram Cancer Center (VICC) are featured in Clinical Cancer Advances 2020: ASCO’s Annual Report on Progress Against Cancer.

Five things to know about China’s coronavirus outbreak

Vanderbilt infectious diseases specialist Thomas Talbot, MD, MPH, answers questions about the current novel coronavirus outbreak in China.

Vanderbilt-Ingram Cancer Center patient first for new cell engineering platform

Rhea Dodd is the first patient treated with an experimental cancer vaccine derived from a completely new cell engineering platform.

1 68 69 70 71 72 125